Johnson & Johnson’s prescription for growth

Published on December 6, 2023

J&J projects 5-6% revenue growth in 2024, fueled by strong core businesses, acquisitions, and a robust pipeline targeting $57 billion in drug sales by 2025.

Continue reading on website
Other news

George Santos Is Making Six Figures on Cameo, According to a New Report

December 6, 2023
He's on a path to eclipse his $174,000 Congressional salary.

Here's How Our Company Tripled in Size By Creating a Culture of Bold Kindness

December 6, 2023
Here's how we've accelerated the growth of our company and developed our people by creating a culture of bold kindness.